NCT07809347 Evaluation of the Factors Associated With BRADYcardia Following Pulmonary Vein Isolation Using Pulsed Field Ablation
| NCT ID | NCT07809347 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wroclaw Medical University |
| Condition | Atrial Fibrillation (AF) |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-01-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2026-01-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aims to identify factors associated with bradycardia during the hospital stay after ablation of atrial fibrillation performed with pulsed field technology.
Eligibility Criteria
Inclusion Criteria: \- Pulmonary vein isolation performed with PFA Exclusion Criteria: * Permanent pacemaker * CRT device * Dual-chamber ICD * Cardiac tamponade * Acute stroke * Acute bleeding requiring surgical intervention
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07809347 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Atrial Fibrillation (AF). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07809347 currently recruiting?
Yes, NCT07809347 is actively recruiting participants. Contact the research team at pnsky@wp.pl for enrollment information.
Where is the NCT07809347 trial being conducted?
This trial is being conducted at Wroclaw, Poland.
Who is sponsoring the NCT07809347 clinical trial?
NCT07809347 is sponsored by Wroclaw Medical University. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.